Cargando…

Myelodysplasia is in the niche: novel concepts and emerging therapies

Myelodysplastic syndromes (MDSs) represent clonal disorders mainly of the elderly that are characterized by ineffective hematopoiesis and an increased risk of transformation into acute myeloid leukemia. The pathogenesis of MDS is thought to evolve from accumulation and selection of specific genetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bulycheva, E, Rauner, M, Medyouf, H, Theurl, I, Bornhäuser, M, Hofbauer, L C, Platzbecker, U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320287/ https://www.ncbi.nlm.nih.gov/pubmed/25394715 http://dx.doi.org/10.1038/leu.2014.325

Ejemplares similares

Antineutrophil cytoplasmic antibodies in myelodysplasia.
por: Hull, D. R., et al.
Publicado: (1996)

CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC
por: Tirado-Gonzalez, I, et al.
Publicado: (2017)

Endothelial Progenitor Cell Dysfunction in Myelodysplastic Syndromes: Possible Contribution of a Defective Vascular Niche to Myelodysplasia()()
por: Teofili, Luciana, et al.
Publicado: (2015)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

Temozolomide-Induced Myelodysplasia
por: Natelson, Ethan A., et al.
Publicado: (2010)

Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway
por: Balaian, Ekaterina, et al.
Publicado: (2018)

Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
por: Weidner, Heike, et al.
Publicado: (2022)

Bone Marrow Immunity and Myelodysplasia
por: Lambert, Claude, et al.
Publicado: (2016)

Acquired spherocytosis in the setting of myelodysplasia
por: Karlsson, Linda Katharina, et al.
Publicado: (2022)

New Insights on Iron Study in Myelodysplasia
por: El Husseiny, Noha M., et al.
Publicado: (2014)

Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells
por: Wobus, Manja, et al.
Publicado: (2021)

Is Myelodysplasia a Consequence of Normal Aging?
por: Heibl, Sonja, et al.
Publicado: (2021)

Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
por: Veiga, Camilla Bertuzzo, et al.
Publicado: (2021)

UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
por: Georgi, Julia-Annabell, et al.
Publicado: (2023)

Bone progenitor dysfunction induces myelodysplasia and secondary leukemia
por: Raaijmakers, Marc H.G.P., et al.
Publicado: (2010)

Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog
por: Natelson, Ethan A., et al.
Publicado: (2013)

Myelodysplasia and Mast Cell Leukemia with t(9;22)
por: Lago, Kathryn J., et al.
Publicado: (2017)

Methotrexate-induced myelodysplasia mimicking myelodysplastic syndrome
por: Kawase, Yuuki, et al.
Publicado: (2018)

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
por: Aujla, Amandeep, et al.
Publicado: (2018)

Copper and Zinc Feud: Is This Myelodysplasia or Myelodysplastic Syndrome?
por: Kumar, Manoj, et al.
Publicado: (2022)

Established and Emerging Concepts to Treat Imbalances of Iron Homeostasis in Inflammatory Diseases
por: Petzer, Verena, et al.
Publicado: (2018)

AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
por: Koenig, Kristin L., et al.
Publicado: (2020)

Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome
por: Faraji‐Goodarzi, Mojgan, et al.
Publicado: (2020)

TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
por: Testa, Ugo, et al.
Publicado: (2023)

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
por: Abdel-Wahab, Omar, et al.
Publicado: (2013)

Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia
por: Kast, Richard E.
Publicado: (2018)

Management of neurogenic bladder in myelodysplasia patients: experience at our center
por: Singh, Sangram, et al.
Publicado: (2010)

Uncovering Clinical Features of De Novo Philadelphia Positive Myelodysplasia
por: Armas, Aristides, et al.
Publicado: (2017)

Acute myeloid leukemia with myelodysplasia-related changes and basophilic differentiation
por: Rieu, Jean-Baptiste, et al.
Publicado: (2020)

The niche party concept and its measurement
por: Meyer, Thomas M, et al.
Publicado: (2015)

P2RY8-CRLF2 Fusion–Positive Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Response to Novel Therapy
por: Aypar, Umut, et al.
Publicado: (2020)

Glioblastoma: Microenvironment and Niche Concept
por: Schiffer, Davide, et al.
Publicado: (2018)

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
por: McCarter, Joseph G. W., et al.
Publicado: (2023)

Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1 mutated myelodysplasia
por: Mian, Syed A, et al.
Publicado: (2023)

Detection of chromosomal 7 loss in myelodysplasia using an extremely polymorphic DNA probe.
por: Thein, S. L., et al.
Publicado: (1988)

Recent advances in myelodysplasia: update from 2011 ASH annual meeting
por: Liu, Delong
Publicado: (2012)

Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis
por: Inoue, Daichi, et al.
Publicado: (2016)

The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020)

PB2086: SIMULTANEOUS DIAGNOSIS OF MULTIPLE MYELOMA AND MYELODYSPLASIA: CASE REPORT.
por: Benabed, Khaled, et al.
Publicado: (2023)

Regulation of the Bone Marrow Niche by Inflammation
por: Mitroulis, Ioannis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k41464ue1rhomce9pnaii7a79t